To estimate the cost of dementia and the extra cost of caring for someone with dementia over the cost of caring for someone without dementia. DESIGN: We developed an evidence-based mathematical model to simulate disease progression for newly diagnosed individuals with dementia. Data-driven trajectories of cognition, function, and behavioral and psychological symptoms were used to model disease progression and predict costs. Using modeling, we evaluated lifetime and annual costs of individuals with dementia, compared costs of those with and without clinical features of dementia, and evaluated the effect of reducing functional decline or behavioral and psychological symptoms by 10% for 12 months (implemented when Mini-Mental State Examination score ≤21). SETTING: Mathematical model. PARTICIPANTS: Representative simulated U.S. incident dementia cases. MEASUREMENTS: Value of informal care, out-of-pocket expenditures, Medicaid expenditures, and Medicare expenditures. RESULTS: From time of diagnosis (mean age 83), discounted total lifetime cost of care for a person with dementia was $321,780 (2015 dollars). Families incurred 70% of the total cost burden ($225,140), Medicaid accounted for 14% ($44,090), and Medicare accounted for 16% ($52,540). Costs for a person with dementia over a lifetime were $184,500 greater (86% incurred by families) than for someone without dementia. Total annual cost peaked at $89,000, and net cost peaked at $72,400.
M ore than 5 million Americans live with dementia. 1 As the population ages, this number will increase, placing significant burden on families, the long-term care system, and the economy. 1 The societal economic burden of dementia consists of different types of costs (value of informal care, out-of-pocket expenditures, Medicaid expenditures, Medicare expenditures), and several payers (family, Medicaid, Medicare) bear various amounts of the economic responsibility. To facilitate planning at the family, state, and federal levels, policy-makers must better understand who incurs dementia costs over the life course of the disease. 2 Two recent studies highlight the economic burden of the disease over short periods of time. One found that, in the last 5 years of life, a person with dementia receives more than $250,000 worth of care. 3 The other found that those with dementia receive more than $56,000 more care in any given year than those without dementia. 4 In both studies, families incurred the greatest cost burden because of informal caregiving and out-of-pocket payments for formal long-term care services, but neither study accounted for the dynamic processes and substantial variations that occur in symptom presentation (cognitive and functional decline, behavioral and psychological symptoms of dementia) over the course of the disease.
We estimated the total lifetime and annual costs of dementia care and the extra cost of caring for someone with dementia compared with someone without dementia (net cost) using a comprehensive U.S. dementia microsimulation model. Our model overcomes the limitations of previous dementia simulation models by synthesizing data from a clinical registry, a nationally representative survey, and Centers for Medicare and Medicaid Services (CMS) Medicare data to model cognitive, functional, and behavioral and psychological trajectories and associated resource use.
METHODS

Model Design
Our evidence-based individual-level model simulated the disease progression (cognition, function, behavioral and psychological symptoms), place of residence (community or long-term care facility), and Medicaid status (dual enrollment) of a person newly diagnosed with dementia to estimate the lifetime and full range of annual costs of care.
Specifically, an individual entered the model as a community-dwelling incident case. At the point of entry (diagnosis of dementia) and before disease progression, the personal characteristics of the person with dementia (e.g., age) and the characteristics of a primary caregiver were randomly generated from published incident statistics or derived from observational data (data sources described below). Table S1 details the baseline characteristics. 5, 6 This allowed the simulated population to be as representative as possible of the general population. As described in detail below, when the person with dementia aged (progressed through the model in monthly increments), their cognition, function, and behavioral and psychological symptoms (clinical features) changed, and they could experience transitions between places of residence, transitions from Medicare only to dual enrollment, and death from dementia or other causes. [7] [8] [9] [10] Personal characteristics, clinical features, place of residence, and insurance status were used to predict costs.
Measures of Disease Progression: Cognition, Function, and Behavioral and Psychological Symptoms
Dementia progression was modeled using three key clinical features: cognition, function, and behavioral and psychological symptoms. 11 Cognition was modeled using the Mini-Mental State Examination (MMSE), which is scored from 0 to 30, with lower scores indicating greater cognitive impairment. 12 Function was modeled as the number of 10 functional limitations present and scored from 0 to 10, with higher scores indicating more limitations (Table S2 ). Behavioral and psychological symptoms were modeled as the number of 12 symptoms present based on symptoms in the Neuropsychiatric Inventory Questionnaire version Q (Table S3 ). These measures of the clinical features were chosen because they are consistent with the measures available in the data used to predict clinical trajectories, transitions in place of residence, and cost (prediction equations described below). [13] [14] [15] Modeling Disease Progression To model disease progression over time, we adapted previously developed cognitive, functional, and behavioral and psychological mixed-effects regression trajectory models of incident dementia cases (Table 1) . 13 These models used longitudinal data from the Uniform Data Set of the National Alzheimer's Coordinating Center, which contains data from 34 Alzheimer's Disease Centers (ADCs), to estimate separate trajectories of the three clinical features over time. 6 During annual assessments, trained ADC providers administered a standardized protocol that included cognitive, functional, and behavioral and psychological assessments. The trajectory models included explanatory variables believed to be risk factors for disease onset and decline. (Tables S4-S6 report model coefficients for each trajectory model).
Transitions Between Place of Residence, Medicare Only to Dual Enrollment, and Death
Risk of transitioning to a long-term care facility was modeled using the Uniform Data Set. These long-term care admissions were assumed to be independent of Medicare-covered skilled nursing admissions because our estimates of Medicare expenditures (described below) included those for skilled nursing care. The few observed transitions in the data of individuals moving from the facility back to the community, indicating that most of the long-term care admissions were for nonMedicare covered care, supported this assumption. To model long-term care admissions, we developed a parametric survival model to enable extrapolation beyond the available data and to predict the absolute risk of being institutionalized. We chose to use a Weibull survival model rather than an exponential or Gompertz model based on visual inspection of the hazard functions and because the Weibull model had the lowest Akaike Information Criterion. 16 Our longterm care facility risk model included lagged terms for the clinical features and potential confounders (Table 1) . Table S7 reports Weibull model coefficients.
Although individuals can transition from a long-term care facility to the community, few such transitions occurred in the Uniform Data Set. We used published estimates of long-term care facility discharge rates to model transition back to the community (Table 1) . 17 For persons with dementia not dually enrolled at disease onset, the risk of transitioning to Medicare or Medicaid varied according to place of residence. Individuals in the community had lower monthly risk (monthly transition probability = 0.00206) of transitioning to Medicare-Medicaid than those in a long-term care facility (monthly transition probability = 0.01056) ( Table 1) . 18, 19 Individuals with dementia who transitioned from a long-term care facility to the community continued to face greater risk of transitioning to Medicare or Medicaid for 6 months.
Mortality was modeled using background age-, sex-, and race-mortality rates obtained from U.S. life tables. 10 We then used a generalized reduced gradient method to calibrate age-, sex-, and race-specific hazard ratios to match published median dementia survival times based on age of disease onset (≤75, 76-80, 81-85, >85).
7,20
Costs and Time Spent Caregiving
We used published regression equations based on data from the nationally representative Aging, Demographics, and Memory Study, 5 a subsample of the Health and Retirement Study, 21 linked to CMS Medicare data to predict monthly hours spent receiving informal care, monthly out-of-pocket medical expenditures, and monthly Medicare expenditures. 14, 15 Using the same data, we estimated a regression equation to predict monthly hours spent receiving formal community based caregiving (Table 1; Table S8 ). All the regression models included main effects for the clinical features and potential confounding variables and were estimated using the sampling weights from the Aging, Demographics, and Memory Study.
The value of informal caregiving was $19.71 per hour (weighted average of informal caregiving of $22.26 per hour for those <65 and $14.76 per hour for those ≥65), and the value of formal caregiving was $23 per hour.
22,23
We multiplied predicted monthly hours of informal and formal caregiving by the value of the care. In our base case, approximately 11.7 hours of informal caregiving per day ($19.71 per hour) was equivalent to the daily private nursing home pay rate ($231 per day) ( Table 1) .
To model long-term care facility expenditures, we multiplied time spent in the facility by the daily pay rate, taking into account differences in pay rate for private payand Medicaid-covered individuals (Table 1) . 22, 24 Finally, Medicaid expenditures for those in the community were $900 per month. 25, 26 Costs were discounted by 3% annually over an individual's lifetime after a diagnosis of dementia and are reported in 2015 dollars.
Statistical Analysis
In the base-case analysis, we simulated individual incident dementia cases to estimate mean lifetime and annual (conditional on surviving the entire year) total cost of care (value of informal care, Medicaid expenditures, Medicare expenditures, and individual out-of-pocket expenditures (medical care, long-term care, formal care)) Step 1: Disease Progression Cognition Function Behavioral and psychological symptoms Linear mixed-effects models directly estimated from data (Table S4) National Alzheimer's Coordinating Center 6, 13 Step Step 4: Mortality Mortality Age-, sex-, and race-mortality rates and dementia-specific hazard rate US life tables and Brookmeyer et al. 7, 20 Persons with dementia were individually simulated. At point of entry (diagnosis), the model generated the characteristics of the person with dementia (age, sex, education, race, marital status, region of residence, insurance status, household income, number of children, comorbidities) and of the primary caregiver (if the caregiver lives with the person with dementia, relationship between person with dementia and caregiver). During each monthly cycle, an individual's cognitive and functional abilities and number of behavioral and psychological symptoms were determined (Step 1). The clinical features and personal characteristics were used to determine transitions (Step 2). Personal characteristics, the clinical features, place of residence, and insurance status were used to estimate cost of care (Step 3). If an individual was predicted to survive (Step 4) the cycle, then the simulated person with dementia repeated Steps 1 to 4. If they were predicted to die, then they exited the model. a Models the risk of long-term care facility admissions excluding admissions for Medicare-covered skilled nursing care.
b If a person with dementia did not leave the long-term care facility within a year, it was assumed that they remained in the facility for life.
c Once an individual was dually eligible, it was assumed they would enroll in Medicaid and remain on Medicaid for life. Background Medicaid transition risk for community-dwelling individuals without dementia was 0.0008. Individuals with dementia had an excess transition risk (hazard ratio = 2.575). All individuals residing in a facility had a 0.0085 added Medicaid transition risk.
d
Medicaid expenditures for those with dementia residing in the community. In counterfactual analyses, Medicaid expenditures for those without dementia were $810.
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We conducted a counterfactual analysis to determine what would have happened to the same simulated person had they not had any cognitive deficits, functional limitations, behavioral and psychological symptoms, excess Medicaid transition risk, or excess mortality due to dementia. We then compared expected costs between the simulated person with dementia and his or her counterfactual dementia free version (net cost). We also conducted a series of counterfactual analyses to determine the extra cost of caring for someone with dementia compared with individuals with one, three, or five functional limitations and no cognitive deficits, no behavioral and psychological symptoms, and no excess Medicaid or mortality risk due to dementia.
Policy-makers need a framework to be able to estimate the potential economic effect of policies and interventions that support individuals with dementia. 2 To that end, we demonstrated the application of the model as a tool to evaluate the effects of interventions that can alter the trajectory of functional decline or behavioral and psychological symptoms. Specifically, we used the model to evaluate what would happen if an intervention were introduced that reduced functional decline by 10% or reduced the increase in number of behavioral and psychological symptoms by 10%. In this analysis, we assumed that the hypothetical intervention was implemented during the early stage of the disease (MMSE score ≤21) and that treatment effects lasted for 12 months. After 12 months, individuals experienced the same trajectories as those in the base case.
Subanalyses were performed to determine outcomes according to age of dementia onset (75 and 90). A second set of subanalyses was performed to evaluate results assuming different values of informal care (base case, $19.71 per hour; low value, $10 per hour; high value, $28 per hour).
The preferred method for evaluating uncertainty is to conduct a probabilistic sensitivity analysis, 27 ,28 but we estimated that more than 100 million iterations in the probabilistic sensitivity analysis would be needed to achieve convergence, and this was not feasible given our computational resources. Therefore, to assess the effect of uncertainty on the cost of dementia, we evaluated outcomes when select parameters were set to their best-and worstcase values (Table S9 details 
RESULTS
From the time of diagnosis (base case mean age 83, life expectancy 60 months; Figure S1 reports distribution of survival time according to place of residence and insurance status), mean discounted lifetime total value of care was $321,780 per person with dementia ( Figure 1A) . Families incurred 70% of the total cost burden ($135,300 in the value of informal care, $89,840 in cash out-of-pocket payments), Medicaid payments ($44,090) accounted for 14%, and Medicare payments ($52,540) accounted for 16%. The annual total cost of dementia was not constant and peaked at 5 years ($89,900) after dementia onset ( Figure S2) .
In counterfactual analysis, someone without dementia incurred $137,280 in expenditures. Thus, an individual with dementia experienced $184,500 more cost over a lifetime than someone without dementia ( Figure 1A) . Families shouldered the largest net cost burden (86% of net cost incurred by all parties) because of excess informal caregiving ($132,850 more caregiving received) and out-of-pocket payments ($25,110 more out-of-pocket spending). Medicaid ($6,640) and Medicare ($19,890) payments accounted for 4% and 11% of net dementia cost, respectively. The annual net cost of dementia peaked in the fifth year after dementia onset ($72,400) ( Figure 1B ). An individual with dementia received $168,990, $130,510, and $70,670 more care over a lifetime than an individuals with one, three, or five functional limitations (but no cognitive limitations or behavioral and psychological symptoms), respectively (Table S10) .
Finally, a hypothetical intervention (implemented when MMSE score was ≤21 and with a 12-month treatment effect) that reduced the rate of functional decline by 10% resulted in a $3,880 lower lifetime cost than someone who received usual dementia care (Table S10 ). An intervention that reduced the number of behavioral and psychological symptoms by 10% resulted in a $680 lower lifetime cost.
In subanalyses, the mean total (net) value of care for a 75-year-old individual with incident dementia was $527,920 ($264,390). A 90-year-old individual with dementia incurred $248,980 (net $183,680) worth of care. When just the value of informal care was set to the low estimate ($10 per hour) the total (net) cost of dementia was $255,120 ($119,050). Conversely, when just the value of informal care was set to the high estimate ($28 per hour) the total (net) cost of dementia was $378,690 ($240,370). Finally, the total (net) costs of dementia in the best-and worst-case analyses were $214,700 ($111,500) and $420,850 ($242,500), respectively ( Figure S3 ).
DISCUSSION
The economic burden of Alzheimer's disease and related dementias and who pays such costs over the course of these conditions are of great policy relevance but cannot be directly estimated from existing data. We present a novel dementia policy model that synthesized data from a clinical registry, a nationally representative survey, and CMS Medicare data to model dementia clinical features, living arrangements, and insurance status over the life expectancy of an individual with dementia to inform policy-makers of the cost of dementia. We found that total and net costs of dementia over a lifetime of dementia were $321,780 and $184,500, respectively.
Our evaluation of the annual net cost of dementia revealed that total cost increased for the first 5 years after onset and then began to decrease slowly. At the same time, out-of-pocket and Medicaid expenditures increased with time. In the early years after dementia onset, individuals in our model resided in the community. During this period, the amount of informal caregiving increased, leading to greater costs. Eventually, individuals in the model began entering long-term care facilities, which resulted in an increase in net out-of-pocket and Medicaid expenditures, but on average, this increase was less than the value of the substituted informal care (11.7 hours of informal care valued at $19.71 per hour is equivalent to a daily nursing home private pay rate of $231). Simultaneously, costs in the dementia-free (counterfactual) individuals were increasing over time. The shift in locus of care combined with increasing cost in the counterfactual individuals resulted in lower cumulative net expenditures.
Our results highlight how the financial burden of dementia varies based on payer. How and who pays for cost over time change from being attributable to informal care to out-of-pocket and Medicaid payments. At all times, families incur the largest financial burden, highlighting the importance and value of informal caregiving for individuals with dementia. 29, 30 From a government budgetary perspective, informal caregiving is often viewed as a free or low-cost source of care, yet there are potentially unintended long-term consequences for caregivers (e.g., long-term health consequences). 31 Moreover, demographic trends indicate that the potential number of family caregivers available to provide such care to persons with dementia may decrease considerably in the upcoming decades. 29, 30 There is continued enthusiasm from policy-makers to implement policies and interventions that reduce long-term care facility admissions and length of stay. [32] [33] [34] With reductions in long-term care facility use (and perhaps acute and rehabilitative care as well), informal caregivers will be relied upon to provide even more care. If policy-makers are going to continue to rely on informal caregivers, they should provide them with effective and proven support. 30 Effective long-term care policy should promote highquality care (e.g., family-centered models that include rich sources of community-based support). Sometimes high-quality care costs more, but such costs largely rely on the perspective of the payer (e.g., informal caregiver, Medicaid, and Medicare).
A review of model inputs indicates that reductions in all costs can be generated from proven interventions that alter functional and behavioral and psychological symptom trajectories, but the magnitude of savings will depend on effect sizes and their duration. For example, clinical trials of nondrug interventions have reported reductions in functional decline and number of behavioral and psychological symptoms, but trials have reported limited economic outcomes (e.g., time in a nursing home). [35] [36] [37] [38] [39] [40] Future studies can use our model to connect the clinical benefits of proven interventions with economic outcomes. Our evaluation of hypothetical treatments found that reducing the rate of functional decline or number of behavioral and psychological symptoms by 10% for 12 months (implemented when the MMSE score is ≤21) reduced lifetime costs by $3,880 and $680, respectively. These savings are small relative to the total disease burden, but they still may represent important savings depending on the perspective of the payer.
Although we approach the modeling of dementia cost differently, we derive estimates similar to those of others in the literature for annual net cost, supporting the validity of our model. 3, 4, 41 For example, from the third to the tenth year, annual net costs in our model fall within the confidence interval (CI) of the net cross-sectional cost of dementia reported by the RAND study (values in the RAND analysis updated to 2015 dollars for comparison with our results: $64,750, 95% CI = $49,170-80,330). 4 We extend results from prior studies by modeling disease progression from incidence to death. [42] [43] [44] [45] Most importantly, our dementia policy model serves as a flexible tool to evaluate treatments and their effects on policy-relevant outcomes that are not normally captured in randomized trials.
Our study has several limitations. Because of limited data, our estimates of the cost of dementia do not take into account the long-term health consequences of caregiving. Our simulation model uses several risk equations, each with a number of parameters. If parameters are incorrectly specified in the original risk equations, our predicted values may be biased. At times, the simulation model may extrapolate beyond the original data, which may result in unrepresentative predictive values. Despite these potential limitations, our results of annual net cost from the second to tenth year match those of the previous study. 4 In conclusion, individuals with dementia receive $321,780 worth of total care over the course of the disease, which equates to $184,500 more than if they did not have dementia. Families bear most of the total and net costs for informal care and out-of-pocket payments. Policy and services should be implemented to support family members in the community.
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